{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:56:11Z","timestamp":1792601771965,"version":"4.5.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.humpath.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T03:17:14Z","timestamp":1690946234000},"page":"170-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose"],"prefix":"10.1016","volume":"141","author":[{"given":"Ashley E.","family":"Stueck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-6313","authenticated-orcid":false,"given":"M. Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.07.007_bib1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American society for blood and marrow transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2023.07.007_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41409-019-0598-x","article-title":"HLA-haploidentical hematopoietic stem cell transplantation in pediatric patients with hemoglobinopathies: current practice and new approaches","volume":"54","author":"Oevermann","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ajcp\/aqw050","article-title":"Histopathology of graft-vs-host disease of gastrointestinal tract and liver: an update","volume":"145","author":"Salomao","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2006.00573.x","article-title":"Graft-vs.-host disease in lung and other solid organ transplant recipients","volume":"21","author":"Assi","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tmrv.2008.09.006","article-title":"Transfusion-associated graft-versus-host disease","volume":"23","author":"Ruhl","year":"2009","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.humpath.2023.07.007_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/petr.12721","article-title":"Graft-versus-host disease in paediatric solid organ transplantation: a review of the literature","volume":"20","author":"Green","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00000478-200007000-00012","article-title":"Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation","volume":"24","author":"Saunders","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib10","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1182\/blood-2002-01-0176","article-title":"Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD","volume":"100","author":"Miura","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/bmt.2015.205","article-title":"Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation","volume":"51","author":"Arai","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41409-019-0464-x","article-title":"Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement","volume":"54","author":"Karlas","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbmt.2015.12.020","article-title":"Late acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Omer","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238824","article-title":"Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality","volume":"15","author":"Maung","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2023.07.007_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.humpath.2023.07.007_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1148\/radiol.10100025","article-title":"Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation","volume":"258","author":"Mahgerefteh","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.humpath.2023.07.007_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/17474086.2020.1709436","article-title":"The role of regulatory T cells in graft-versus-host disease management","volume":"13","author":"Whangbo","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1057694","article-title":"Controversies and expectations for the prevention of GVHD: a biological and clinical perspective","volume":"13","author":"Watkins","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2023.07.007_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2559.2007.02679.x","article-title":"Histopathology of graft versus host disease of the liver","volume":"50","author":"Quaglia","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.07.007_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft-versus-host disease: national Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report","volume":"12","author":"Shulman","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41409-022-01764-w","article-title":"Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review","volume":"57","author":"Holtan","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and supportive care working group report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ajh.25575","article-title":"Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients","volume":"94","author":"Modi","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00042737-200412000-00019","article-title":"Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation","volume":"16","author":"El-Sayed","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2023.07.007_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbmt.2005.06.008","article-title":"Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver","volume":"11","author":"Duarte","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib28","first-page":"1306","article-title":"Steroid-responsive chronic hepatic graft-versus-host disease without extrahepatic graft-versus-host disease","volume":"84","author":"Gholson","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2023.07.007_bib29","first-page":"319","article-title":"Severe isolated acute hepatic graft-versus-host disease with vanishing\u00a0bile\u00a0duct syndrome","volume":"14","author":"Yeh","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","article-title":"Pathophysiology of GvHD and other HSCT-related major complications","volume":"8","author":"Ghimire","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2023.07.007_bib31","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.humpath.2013.02.023","article-title":"CD123 is a useful immunohistochemical marker to facilitate diagnosis of acute graft-versus-host disease in colon","volume":"44","author":"Lin","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2006-12-022038","article-title":"The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia","volume":"110","author":"Chakraverty","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib33","first-page":"S21","article-title":"Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD)","volume":"7","author":"Matsukuma","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.humpath.2023.07.007_bib34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/jhep.2000.20067","article-title":"Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis","volume":"32","author":"Strasser","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2023.07.007_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/petr.12623","article-title":"HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT","volume":"20","author":"Thorvaldson","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib36","first-page":"747 e741","article-title":"Characterization of hepatic dysfunction in subjects diagnosed with chronic GVHD by NIH consensus criteria","volume":"28","author":"Yang","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.humpath.2023.07.007_bib37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbmt.2007.03.012","article-title":"Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality","volume":"13","author":"McCune","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bbmt.2013.04.005","article-title":"Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes","volume":"19","author":"Rezvani","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/PAP.0000000000000032","article-title":"Hematopoietic stem cell transplantation: graft versus host disease and pathology of gastrointestinal tract, liver, and lung","volume":"21","author":"Kambham","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.leukres.2006.07.005","article-title":"Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project","volume":"31","author":"McKoy","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2023.07.007_bib41","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbmt.2010.01.004","article-title":"A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.humpath.2023.07.007_bib43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbmt.2006.01.004","article-title":"Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Kamble","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humpath.2017.06.011","article-title":"Liver biopsy findings in patients with hematopoietic cell transplantation","volume":"66","author":"Eskandari","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib45","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/hep4.1965","article-title":"Abnormal liver tests are not sufficient for diagnosis of hepatic graft-versus-host disease in critically ill patients","volume":"6","author":"Yang","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.humpath.2023.07.007_bib46","first-page":"1849","article-title":"Clinicopathological features in patients with hepatic graft-versus-host disease","volume":"52","author":"Chiba","year":"2005","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.humpath.2023.07.007_bib47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.1840080305","article-title":"A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation","volume":"8","author":"Shulman","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2023.07.007_bib48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ajcp\/aqab215","article-title":"Hepatitic variant of graft-vs-host disease","volume":"157","author":"Liang","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib49","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1182\/blood-2002-03-0857","article-title":"Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion","volume":"100","author":"Akpek","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.bmt.1705400","article-title":"A case of hepatic graft-versus-host disease complicating autologous stem cell transplantation for relapsed Hodgkin's disease","volume":"38","author":"Cutting","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-013-1528-8","article-title":"Liver Pathology Group of the German-Austrian-Swiss Working Group on Gv HD. Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation","volume":"464","author":"Stift","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2023.07.007_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jum.14717","article-title":"Quantitative assessment of liver stiffness using ultrasound shear wave elastography in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a pilot study","volume":"38","author":"Zhang","year":"2019","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/rg.252045037","article-title":"Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation","volume":"25","author":"Coy","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.humpath.2023.07.007_bib54","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1016\/j.transproceed.2010.08.041","article-title":"Hepatic artery resistance index at Doppler ultrasonography is a useful parameter of hepatic graft-vs-host disease after allogeneic stem cell transplantation","volume":"42","author":"Song","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humpath.2023.07.007_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43046-020-0020-1","article-title":"Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience","volume":"32","author":"Abdelbary","year":"2020","journal-title":"J Egypt Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2023.07.007_bib56","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.bbmt.2011.04.009","article-title":"Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patients","volume":"17","author":"Barba","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1705004","article-title":"GI complications in pediatric patients post-BMT","volume":"36","author":"Barker","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bmt.1702453","article-title":"Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study","volume":"26","author":"Kim","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib59","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2006.07.013","article-title":"Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases","volume":"12","author":"Kusumi","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib60","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/01.TP.0000120383.30088.A4","article-title":"Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication","volume":"77","author":"Ma","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2023.07.007_bib61","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ejh.13309","article-title":"Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking\u00a0acute graft versus host disease","volume":"103","author":"Prem","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ajcp\/aqaa225","article-title":"The utility of liver biopsy in the evaluation of liver disease and abnormal liver function tests","volume":"156","author":"Khalifa","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trim.2010.03.002","article-title":"Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form","volume":"23","author":"Ali","year":"2010","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.humpath.2023.07.007_bib64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-199809000-00005","article-title":"Outcomes of recipients of both bone marrow and solid organ transplants","volume":"77","author":"Dey","year":"1998","journal-title":"A review. Medicine (Baltimore)"},{"key":"10.1016\/j.humpath.2023.07.007_bib65","first-page":"652","article-title":"Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients","volume":"87","author":"Picardi","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2023.07.007_bib66","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"American association for the study of liver D. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2023.07.007_bib67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/152581602753658420","article-title":"A systematic approach to hepatic complications in hematopoietic stem cell transplantation","volume":"11","author":"Arai","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.humpath.2023.07.007_bib68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bmt.1703278","article-title":"Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease","volume":"28","author":"Jacobsohn","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib69","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12885-016-2603-8","article-title":"Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study","volume":"16","author":"Maximova","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2023.07.007_bib70","first-page":"655","article-title":"Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management","volume":"17","author":"Iqbal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00042737-200402000-00006","article-title":"Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy","volume":"16","author":"Ho","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2023.07.007_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1532\/IJH97.A10319","article-title":"Chronic graft-versus-host disease of the liver presenting as an acute hepatitis following nonmyeloablative hematopoietic stem cell transplantation","volume":"79","author":"Maeng","year":"2004","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib73","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/modpathol.2017.151","article-title":"Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease","volume":"31","author":"Stueck","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib74","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/hep.26024","article-title":"Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation","volume":"57","author":"Beleoken","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2023.07.007_bib75","first-page":"369","article-title":"Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection","volume":"99","author":"Beschorner","year":"1980","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib76","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199012000-00023","article-title":"Nuclear magnetic resonance of hepatic graft-versus-host disease in mice","volume":"50","author":"Blatter","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2023.07.007_bib77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00004836-198003000-00009","article-title":"The liver in long-term survivors of marrow transplant--chronic graft-versus-host disease","volume":"2","author":"Berman","year":"1980","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.humpath.2023.07.007_bib78","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1034\/j.1600-0676.2002.01734.x","article-title":"Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid","volume":"22","author":"Chiba","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.humpath.2023.07.007_bib79","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.bmt.1702997","article-title":"Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation","volume":"27","author":"Fujii","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib80","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.297.22.2476-b","article-title":"Long-term mortality associated with aprotinin following coronary artery bypass graft surgery","volume":"297","author":"Habib","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2023.07.007_bib81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/pbc.21069","article-title":"Hepatitic pattern of graft versus host disease in children","volume":"49","author":"Melin-Aldana","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2023.07.007_bib82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1066896915610817","article-title":"Autoimmune-like hepatitis: a \"hepatitic\" manifestation of chronic graft versus host disease in post-stem cell transplant","volume":"24","author":"Baniak","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1432-2277.2009.01028.x","article-title":"Successful living donor liver transplantation for severe hepatic GVHD histologically resembling autoimmune hepatitis after bone marrow transplantation from the same sibling donor","volume":"23","author":"Mori","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.humpath.2023.07.007_bib84","first-page":"641","article-title":"A clinicopathological study of 15 autopsy cases with allogeneic bone marrow transplantation in special reference to graft\u00a0versus host disease (GVHD)","volume":"36","author":"Nakamura","year":"1986","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.humpath.2023.07.007_bib85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(80)90735-7","article-title":"Graft-versus-host disease in recipients of syngeneic bone marrow","volume":"1","author":"Sloane","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2023.07.007_bib86","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00007890-198003000-00015","article-title":"Histological and ultrastructural appearance of the liver during graft-versus-host disease complicating bone marrow transplantation","volume":"29","author":"Bernuau","year":"1980","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2023.07.007_bib87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.1840040122","article-title":"Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis","volume":"4","author":"Snover","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2023.07.007_bib88","doi-asserted-by":"crossref","first-page":"85","DOI":"10.12659\/AOT.883462","article-title":"The significance of oral labial biopsy in hepatic graft-versus-host disease diagnosis in patients following allogeneic hematopoietic stem cell transplantation--a preliminary report","volume":"17","author":"Prochorec-Sobieszek","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/15513819309048238","article-title":"Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome","volume":"13","author":"Washington","year":"1993","journal-title":"Pediatr Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib90","first-page":"545","article-title":"An immunohistological study of human hepatic graft-versus-host disease","volume":"62","author":"Dilly","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.humpath.2023.07.007_bib91","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/gut.23.6.465","article-title":"Liver disease after bone marrow transplantation","volume":"23","author":"Farthing","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2023.07.007_bib92","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(87)80571-8","article-title":"Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation","volume":"5","author":"Miglio","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2023.07.007_bib93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00194173","article-title":"Cytomegalovirus in liver biopsies of marrow transplant recipients: detection methods, clinical, histological and immunohistological features","volume":"183","author":"Einsele","year":"1994","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.humpath.2023.07.007_bib94","first-page":"281","article-title":"Intrahepatic periductal glands in graft-versus-host disease","volume":"38","author":"Nakanuma","year":"1988","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.humpath.2023.07.007_bib95","first-page":"179","article-title":"Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation","volume":"63","author":"Kruger","year":"1971","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib96","doi-asserted-by":"crossref","first-page":"9242","DOI":"10.1038\/s41598-021-88824-1","article-title":"Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease","volume":"11","author":"Hagiwara","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2023.07.007_bib97","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib98","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1083-8791(00)70017-6","article-title":"Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire","volume":"6","author":"Margolis","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00277-014-2287-6","article-title":"Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation","volume":"94","author":"Doring","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00277-014-2185-y","article-title":"Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation","volume":"94","author":"Doring","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib101","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAS.0b013e3182082ef6","article-title":"The concept of hepatic artery-bile duct parallelism in the diagnosis of ductopenia in liver biopsy samples","volume":"35","author":"Moreira","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.07.007_bib102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0016-5085(90)91315-W","article-title":"Secondary biliary cirrhosis as a consequence of graft-versus-host disease","volume":"98","author":"Stechschulte","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2023.07.007_bib103","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0016-5085(87)90150-8","article-title":"Cirrhosis as a consequence of graft-versus-host disease","volume":"92","author":"Knapp","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2023.07.007_bib104","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.clinre.2015.06.010","article-title":"Persistent abnormal liver function tests may predict development of cirrhosis in chronic hepatic graft-versus-host disease","volume":"40","author":"Wang","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.humpath.2023.07.007_bib105","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1182\/bloodadvances.2021005286","article-title":"Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival","volume":"5","author":"Pidala","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2023.07.007_bib106","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.2003.03.129","article-title":"Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin","volume":"21","author":"Finke","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2023.07.007_bib107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/07357907.2014.919301","article-title":"Complications of allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Arnaout","year":"2014","journal-title":"Cancer Invest"},{"key":"10.1016\/j.humpath.2023.07.007_bib108","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib109","volume":"61","author":"Akpinar","year":"2022","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.humpath.2023.07.007_bib110","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V85.9.2354.bloodjournal8592354","article-title":"Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia","volume":"85","author":"Casper","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26839","article-title":"Comparison of two cytoreductive regimens for alphabeta-T-cell-depleted haploidentical HSCT in pediatric malignancies: improved engraftment and outcome with TBI-based regimen","volume":"65","author":"Jacoby","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2023.07.007_bib112","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2023.07.007_bib113","first-page":"2196","article-title":"Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia","volume":"93","author":"Ringden","year":"1999","journal-title":"Nordic Bone Marrow Transplantation Group. Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib114","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V83.9.2723.2723","article-title":"A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group","volume":"83","author":"Ringden","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib115","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/pbc.22739","article-title":"Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation","volume":"55","author":"Elhasid","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2023.07.007_bib116","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12185-015-1785-1","article-title":"State-of-the-art acute and chronic GVHD treatment","volume":"101","author":"Jamil","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib117","series-title":"Graft versus host disease. BMJ best practices","author":"Choi","year":"2022"},{"key":"10.1016\/j.humpath.2023.07.007_bib118","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbmt.2009.10.007","article-title":"An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients","volume":"16","author":"Bhatia","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib119","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41409-020-0921-6","article-title":"Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling\u00a0and unrelated donors","volume":"55","author":"Montoro","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1703616","article-title":"Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease","volume":"30","author":"Kumar","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib121","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood.V78.5.1205.1205","article-title":"Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation","volume":"78","author":"Bianco","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib122","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1470-2045(14)71017-4","article-title":"Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1\/2 trial","volume":"15","author":"Kennedy","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2023.07.007_bib123","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1200\/JCO.2010.30.6357","article-title":"Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I\/II controlled, adaptively randomized study","volume":"29","author":"Parmar","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2023.07.007_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213913","article-title":"Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation","volume":"14","author":"de Kort","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2023.07.007_bib125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2023.07.007_bib126","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/14728222.2021.1944101","article-title":"Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes","volume":"25","author":"Richardson","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.humpath.2023.07.007_bib127","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/10600280211068177","article-title":"Impact of defibrotide in the prevention of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation","volume":"56","author":"Tilmont","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.humpath.2023.07.007_bib128","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Nordic Bone Marrow Transplantation G. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbmt.2013.10.014","article-title":"Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study","volume":"20","author":"Ruutu","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib131","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib132","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3324\/haematol.2014.118471","article-title":"Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial","volume":"100","author":"Mielcarek","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2023.07.007_bib133","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.exphem.2009.03.006","article-title":"Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide","volume":"37","author":"Mayer","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib134","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"The E-NIHCGTF. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/14653240802644669","article-title":"A new induction protocol for the control of steroid refractory\/dependent acute graft versus host disease with alefacept and tacrolimus","volume":"11","author":"Shapira","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.humpath.2023.07.007_bib136","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood-2005-12-4851","article-title":"Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin","volume":"107","author":"Van Lint","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib137","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0149-2918(04)90036-7","article-title":"Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial","volume":"26","author":"Bloom","year":"2004","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.humpath.2023.07.007_bib138","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2009-03-212290","article-title":"Blood, Marrow Transplant Clinical Trials N. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network","volume":"114","author":"Alousi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib139","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/14653240903390795","article-title":"Single intra-arterial injection of mesenchymal stromal cells for treatment of steroid-refractory acute graft-versus-host disease: a pilot study","volume":"12","author":"Arima","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.humpath.2023.07.007_bib140","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.transproceed.2007.02.091","article-title":"Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis","volume":"39","author":"Fang","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humpath.2023.07.007_bib141","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1537-2995.2004.00423.x","article-title":"Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease","volume":"44","author":"Perotti","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.humpath.2023.07.007_bib142","first-page":"225","article-title":"Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)","volume":"3","author":"Resnick","year":"2013","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.humpath.2023.07.007_bib143","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jtct.2022.09.004","article-title":"Graft-versus-host disease (GVHD) after post-transplant cyclophosphamide or conventional GVHD prophylaxis: same Title, different song","volume":"28","author":"Solh","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.humpath.2023.07.007_bib144","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbmt.2018.11.017","article-title":"Etanercept as treatment of steroid-refractory acute graft-versus-host disease in pediatric patients","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib145","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood-2004-01-0028","article-title":"Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"Ho","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib146","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3904\/kjim.2014.29.5.630","article-title":"Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib147","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbmt.2004.11.022","article-title":"Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease","volume":"11","author":"Shaughnessy","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib148","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","article-title":"Alpha(1)-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","volume":"131","author":"Magenau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib149","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/15258160050079470","article-title":"Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin","volume":"9","author":"McCaul","year":"2000","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.humpath.2023.07.007_bib150","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood-2017-03-772210","article-title":"Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease","volume":"129","author":"Chen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib151","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ajh.22075","article-title":"Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease","volume":"86","author":"Milner","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib152","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.bmt.1704523","article-title":"Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography","volume":"33","author":"Nakai","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib153","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1365-2141.2002.03923.x","article-title":"Intra-arterial catheter directed therapy for severe graft-versus-host disease","volume":"119","author":"Shapira","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib154","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jca.22012","article-title":"Role of extracorporeal photopheresis in the management of children with graft-vs-host disease","volume":"37","author":"Asensi Canto","year":"2022","journal-title":"J Clin Apher"},{"key":"10.1016\/j.humpath.2023.07.007_bib155","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.bbmt.2014.07.022","article-title":"Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels","volume":"20","author":"Pai","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib156","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jtct.2021.05.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. The 2020 treatment of chronic GVHD report","volume":"27","author":"DeFilipp","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.humpath.2023.07.007_bib157","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood.V100.1.48","article-title":"Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone","volume":"100","author":"Koc","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib159","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbmt.2015.04.023","article-title":"Corticosteroid-free primary treatment of chronic extensive graft-versus-host disease incorporating rituximab","volume":"21","author":"Solomon","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib160","article-title":"Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease","volume":"70","author":"Ali","year":"2022","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib161","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib162","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2004-05-1855","article-title":"Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease","volume":"104","author":"Canninga-van Dijk","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib163","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1537-2995.2011.03542.x","article-title":"Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications","volume":"52","author":"Del Fante","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.humpath.2023.07.007_bib164","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1083-8791(00)70058-9","article-title":"Hydroxychloroquine for the treatment of chronic graft-versus-host disease","volume":"6","author":"Gilman","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib165","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T\u00a0cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib166","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41409-017-0081-5","article-title":"Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease","volume":"53","author":"Khoury","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib167","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib168","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1365-2141.1997.d01-2085.x","article-title":"Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid","volume":"96","author":"Wulffraat","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib169","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/bbmt.2001.v7.pm11400948","article-title":"Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease","volume":"7","author":"Arora","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib170","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V96.12.3995","article-title":"Thalidomide for treatment of patients with chronic graft-versus-host disease","volume":"96","author":"Koc","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib171","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib172","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/1042819031000079096","article-title":"Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease","volume":"44","author":"Flowers","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2023.07.007_bib173","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/lt.20389","article-title":"Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data","volume":"11","author":"Barshes","year":"2005","journal-title":"Liver Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib174","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-199507150-00020","article-title":"Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation","volume":"60","author":"Dowlati","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2023.07.007_bib175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<68::AID-AJH19>3.0.CO;2-3","article-title":"Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation","volume":"52","author":"Figuera","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib176","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1432-2277.2004.00008.x","article-title":"Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up","volume":"18","author":"Orlando","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.humpath.2023.07.007_bib177","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/lt.500020308","article-title":"Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver","volume":"2","author":"Rosen","year":"1996","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.humpath.2023.07.007_bib178","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMc052628","article-title":"Living-donor liver transplantation for chronic hepatic graft-versus-host disease","volume":"354","author":"Shimizu","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib179","first-page":"473","article-title":"Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations","volume":"16","author":"Schlitt","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00277-005-1076-7","article-title":"Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia","volume":"84","author":"Mellgren","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2023.07.007_bib181","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1016\/j.transproceed.2010.09.170","article-title":"Liver transplantation for severe hepatic graft-versus-host disease in two children after hematopoietic stem cell transplantation","volume":"42","author":"Teisseyre","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humpath.2023.07.007_bib182","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.bmt.1703688","article-title":"Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation","volume":"30","author":"Urban","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib183","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3109\/10428194.2013.788178","article-title":"Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant","volume":"54","author":"Zeidan","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2023.07.007_bib184","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/0016-5085(90)91039-9","article-title":"Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation","volume":"99","author":"Rhodes","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2023.07.007_bib185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/TP.0b013e31817c16eb","article-title":"Successful living-donor liver transplantation for chronic hepatic graft-versus-host disease after bone marrow transplantation for chronic granulomatous disease","volume":"86","author":"Yokoyama","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2023.07.007_bib186","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/petr.12009","article-title":"Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single-center experience during 10 yr","volume":"16","author":"Faraci","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib187","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbmt.2010.05.019","article-title":"Blood, marrow transplant clinical trials N. Graft-versus-host disease treatment: predictors of survival","volume":"16","author":"Levine","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib188","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3389\/fimmu.2019.02319","article-title":"Interleukin-6 as biomarker for acute GvHD and survival after allogeneic transplant with post-transplant cyclophosphamide","volume":"10","author":"Greco","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2023.07.007_bib189","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2015-03-636753","article-title":"Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment","volume":"126","author":"McDonald","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood-2014-06-584789","article-title":"High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation","volume":"125","author":"Ponce","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib191","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.07.007_bib192","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood-2016-08-735324","article-title":"Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT","volume":"129","author":"Abu Zaid","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib193","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1182\/blood-2011-08-375006","article-title":"Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease","volume":"118","author":"Ferrara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib194","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","article-title":"Plasma biomarkers of lower\u00a0gastrointestinal and liver acute GVHD","volume":"119","author":"Harris","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib195","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbmt.2015.02.018","article-title":"Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802","volume":"21","author":"Holtan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib196","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/bloodadvances.2018017343","article-title":"Amphiregulin modifies the Minnesota acute graft-versus-host disease risk score: results from BMT CTN 0302\/0802","volume":"2","author":"Holtan","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2023.07.007_bib197","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2017.04.029","article-title":"Predictive value of clinical findings and plasma biomarkers after fourteen days of prednisone treatment for acute graft-versus-host disease","volume":"23","author":"McDonald","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib198","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2006-01-0254","article-title":"An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens","volume":"108","author":"Leisenring","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib199","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.trre.2014.08.001","article-title":"Liver disease after hematopoietic cell transplantation in adults","volume":"29","author":"Norvell","year":"2015","journal-title":"Transplant Rev"},{"key":"10.1016\/j.humpath.2023.07.007_bib200","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1182\/blood-2006-10-049817","article-title":"Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease","volume":"110","author":"Luft","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib201","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2018-01-822957","article-title":"MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD","volume":"131","author":"Major-Monfried","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib202","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbmt.2013.02.001","article-title":"Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study","volume":"19","author":"Pidala","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib203","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"Vigorito","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2023.07.007_bib204","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbmt.2008.09.017","article-title":"Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease","volume":"14","author":"Flowers","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/bbmt.2002.v8.pm11858190","article-title":"Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias","volume":"8","author":"Goerner","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2023.07.007_bib206","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/ejh.13576","article-title":"Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes","volume":"106","author":"Novitzky-Basso","year":"2021","journal-title":"Eur J Haematol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:36Z","timestamp":1758645756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723001594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":206,"alternative-id":["S0046817723001594"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.07.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}